These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
446 related articles for article (PubMed ID: 34128629)
21. Dark Classics in Chemical Neuroscience: Δ Banister SD; Arnold JC; Connor M; Glass M; McGregor IS ACS Chem Neurosci; 2019 May; 10(5):2160-2175. PubMed ID: 30689342 [TBL] [Abstract][Full Text] [Related]
22. Neuroimaging studies towards understanding the central effects of pharmacological cannabis products on patients with epilepsy. Allendorfer JB; Szaflarski JP Epilepsy Behav; 2017 May; 70(Pt B):349-354. PubMed ID: 28109780 [TBL] [Abstract][Full Text] [Related]
24. The Changing Drug Culture: Medical and Recreational Marijuana. Albertson TE; Chenoweth JA; Colby DK; Sutter ME FP Essent; 2016 Feb; 441():11-7. PubMed ID: 26881768 [TBL] [Abstract][Full Text] [Related]
25. Therapeutic Use of Δ9-THC and Cannabidiol: Evaluation of a New Extraction Procedure for the Preparation of Cannabis-based Olive Oil. Morini L; Porro G; Liso M; Groppi A Curr Pharm Biotechnol; 2017; 18(10):828-833. PubMed ID: 29189144 [TBL] [Abstract][Full Text] [Related]
26. Cannabinoids: Therapeutic Use in Clinical Practice. Pagano C; Navarra G; Coppola L; Avilia G; Bifulco M; Laezza C Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328765 [TBL] [Abstract][Full Text] [Related]
27. Simple and Fast Gas-chromatography Mass Spectrometry Assay to Assess Delta 9-Tetrahydrocannabinol and Cannabidiol in Dogs Treated with Medical Cannabis for Canine Epilepsy. Rotolo MC; Graziano S; Pellegrini M; Corlazzoli D; Antinori L; Porcarelli L; Pichini S Curr Pharm Biotechnol; 2017; 18(10):821-827. PubMed ID: 29173160 [TBL] [Abstract][Full Text] [Related]
29. Cannabinoids for Treatment of MS Symptoms: State of the Evidence. Rice J; Cameron M Curr Neurol Neurosci Rep; 2018 Jun; 18(8):50. PubMed ID: 29923025 [TBL] [Abstract][Full Text] [Related]
30. Approved cannabinoids for medical purposes - Comparative systematic review and meta-analysis for sleep and appetite. Spanagel R; Bilbao A Neuropharmacology; 2021 Sep; 196():108680. PubMed ID: 34181977 [TBL] [Abstract][Full Text] [Related]
32. Practical considerations in medical cannabis administration and dosing. MacCallum CA; Russo EB Eur J Intern Med; 2018 Mar; 49():12-19. PubMed ID: 29307505 [TBL] [Abstract][Full Text] [Related]
33. Tetrahydrocannabinol and Cannabidiol Use in an Outpatient Palliative Medicine Population. Highet BH; Lesser ER; Johnson PW; Kaur JS Am J Hosp Palliat Care; 2020 Aug; 37(8):589-593. PubMed ID: 31986898 [TBL] [Abstract][Full Text] [Related]
34. Pharmacology of Medical Cannabis. Amin MR; Ali DW Adv Exp Med Biol; 2019; 1162():151-165. PubMed ID: 31332738 [TBL] [Abstract][Full Text] [Related]
35. Cannabis, cannabidiol, and epilepsy--from receptors to clinical response. Szaflarski JP; Bebin EM Epilepsy Behav; 2014 Dec; 41():277-82. PubMed ID: 25282526 [TBL] [Abstract][Full Text] [Related]
36. Source of cannabinoids: what is available, what is used, and where does it come from? Specchio N; Pietrafusa N; Cross HJ Epileptic Disord; 2020 Jan; 22(S1):1-9. PubMed ID: 31941643 [TBL] [Abstract][Full Text] [Related]
37. Emerging challenges in the extraction, analysis and bioanalysis of cannabidiol and related compounds. Brighenti V; Protti M; Anceschi L; Zanardi C; Mercolini L; Pellati F J Pharm Biomed Anal; 2021 Jan; 192():113633. PubMed ID: 33039911 [TBL] [Abstract][Full Text] [Related]
38. Cannabidiol in medical marijuana: Research vistas and potential opportunities. Rong C; Lee Y; Carmona NE; Cha DS; Ragguett RM; Rosenblat JD; Mansur RB; Ho RC; McIntyre RS Pharmacol Res; 2017 Jul; 121():213-218. PubMed ID: 28501518 [TBL] [Abstract][Full Text] [Related]
39. Can cannabidiol (CBD) help with low back pain? Kulesza B; Mazurek M; Kurzepa J Ann Agric Environ Med; 2023 Sep; 30(3):549-554. PubMed ID: 37772533 [TBL] [Abstract][Full Text] [Related]